VREX - Varex Imaging Corporation
NEXT EARNINGS:
May 14, 2026
EPS Est: $0.20
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$14.50
DETAILS
HIGH:
$14.50
LOW:
$14.50
MEDIAN:
$14.50
CONSENSUS:
$14.50
UPSIDE:
7.65%
Market Cap:
564.65M
Volume:
319,233
Avg Volume:
335,735
52 Week Range:
6.76-14.565
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
0.88
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
2,300
IPO Date:
2017-01-23
EPS (TTM):
-1.70
P/E Ratio:
-7.03
Revenue (TTM):
844.60M
Total Assets:
1.11B
Total Debt:
401.90M
Cash & Equiv:
145.00M
Rev Growth (5Y):
2.7%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
-9.3%
ROCE:
-2.6%
Debt/Equity:
0.85
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-10 | $0.05 | $0.14 | -61.2% | $209.6M | $207.8M | +0.9% |
| 2025-11-18 | $0.37 | $0.18 | +105.6% | $228.9M | $205.8M | +11.2% |
| 2025-08-07 | $0.18 | $0.04 | +350.0% | $203.0M | $219.3M | -7.4% |
| 2025-05-08 | $0.26 | $0.14 | +85.7% | $212.9M | $209.4M | +1.7% |
| 2025-02-06 | $0.07 | $0.04 | +75.0% | $199.8M | $202.2M | -1.2% |
| 2024-11-19 | $0.19 | $0.09 | +111.1% | $205.7M | $189.4M | +8.6% |
| 2024-08-01 | $0.14 | $0.19 | -26.3% | $209.1M | $200.8M | +4.1% |
| 2024-05-02 | $0.16 | $0.23 | -30.4% | $206.2M | $205.2M | +0.5% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 844.60M | 811.00M | 893.40M | 859.40M | 818.10M | 738.30M | 780.60M | 773.40M | 698.10M | 620.10M | 632.30M | 685.20M |
| Net Income | (70.30M) | (47.70M) | 48.20M | 30.30M | 17.40M | (57.90M) | 15.50M | 27.50M | 51.60M | 68.50M | 80.00M | 110.10M |
| EPS | -1.70 | -1.17 | 1.20 | 0.76 | 0.44 | -1.49 | 0.41 | 0.73 | 1.37 | 1.79 | 2.09 | 2.88 |
| Total Assets | 1.11B | 1.22B | 1.25B | 1.18B | 1.15B | 1.14B | 1.04B | 988.50M | 1.04B | 622.40M | 583.60M | 433.10M |
| Total Debt | 401.90M | 470.40M | 469.80M | 436.40M | 459.40M | 484.50M | 395.10M | 389.80M | 483.90M | 0 | 0 | 0 |
| Cash & Equivalents | 145.00M | 168.70M | 152.60M | 89.40M | 144.60M | 100.60M | 29.90M | 51.90M | 83.30M | 36.50M | 20.60M | 500,000 |
| Operating Cash Flow | 41.70M | 47.30M | 108.40M | 16.90M | 92.60M | 13.20M | 71.90M | 85.30M | 75.20M | 74.20M | 85.20M | 118.60M |
| Free Cash Flow | 18.80M | 20.40M | 87.70M | (4.40M) | 77.50M | (10.30M) | 52.10M | 64.90M | 55.00M | 45.30M | 50.90M | 95.40M |
| FCF per Share | 0.45 | 0.50 | 2.18 | -0.11 | 1.97 | -0.27 | 1.36 | 1.71 | 1.46 | 1.19 | 1.33 | 2.50 |
| Book Value | 472.60M | 535.10M | 567.70M | 533.40M | 483.30M | 451.70M | 446.00M | 426.20M | 379.00M | 526.00M | 484.60M | 359.30M |
| Cash & ST Investments | 155.10M | 200.50M | 193.90M | 89.40M | 144.60M | 100.60M | 29.90M | 51.90M | 83.30M | 36.50M | 20.60M | 500,000 |
| ROC Equity | -0.15 | -0.09 | 0.08 | 0.06 | 0.04 | -0.13 | 0.03 | 0.06 | 0.14 | 0.13 | 0.17 | 0.31 |